Načítá se...
Cerivastatin for lowering lipids
BACKGROUND: Cerivastatin was the most potent statin until it was withdrawn from the market due to a number of fatalities due to rhabdomyolysis, however, the dose‐related magnitude of effect of cerivastatin on blood lipids is not known. OBJECTIVES: Primary objective To quantify the effects of various...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2020
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984625/ https://ncbi.nlm.nih.gov/pubmed/31981471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012501.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|